Objective To understand the recently clinical usage of alprostadil injection.
目的:了解前列地尔注射液的临床应用现状。
Objective to explore the infusion methods to reduce phlebitis caused by alprostadil injection.
目的探讨降低前列地尔注射液所致静脉炎的输液方式。
OBJECTIVE: To compare the clinical effects between alprostadil and the traditional therapy in treating sudden deafness.
目的:比较前列地尔与传统方法治疗突发性耳聋的临床疗效。
Objective: To investigate the clinical effect of Shengmai injection combined with alprostadil injection on diabetes peripheral neuropathy.
目的:观察生脉注射液联合前列地尔注射液治疗糖尿病周围神经病变的临床疗效。
To observe and analyze the China Ixeris combine with alprostadil in the treatment of early diabetic nephropathy and summarize its clinical value.
观察和分析苦碟子联合前列地尔治疗早期糖尿病肾病的临床疗效,总结其临床价值。
Conclusion: it is quite effective, on the basis of routine treatment, adding Alprostadil with Pulse-activating injection in the treatment of the patients with UAP.
结论:在常规治疗的基础上加用前列地尔注射液联合生脉注射液治疗不稳定型心绞痛,疗效显著。
The alprostadil nanometer lipid carrier consists of an effective doses of alprostadil, solid lipid material, liquid oil, emulsifier, PEG modified esters and water for injection.
该前列地尔纳米脂质载体由治疗有效量的前列地尔、固态脂质材料、液态油、乳化剂、PEG修饰的酯类和注射用水组成。
Treament group were received conventional therapy and alprostadil with deproteinized calf blood extractives injection, control group were received conventional therapy and mecobalamine.
治疗组在常规治疗基础上给予前列地尔和小牛血去蛋白提取物治疗,对照组在常规治疗基础上给予甲钴胺。
OBJECTIVE To compare the equivalence and safety between reference preparation and test preparation of alprostadil injection in patients with chronic lower extremity arterial occlusive disease.
目的本试验旨在观察种市售前列地尔注射液在治疗下肢慢性动脉闭塞症的等效性和安全性。
OBJECTIVE To compare the equivalence and safety between reference preparation and test preparation of alprostadil injection in patients with chronic lower extremity arterial occlusive disease.
目的本试验旨在观察种市售前列地尔注射液在治疗下肢慢性动脉闭塞症的等效性和安全性。
应用推荐